• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌中c-fos癌蛋白的免疫组织化学定位

Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers.

作者信息

Lee C S, Charalambous D

机构信息

Department of Anatomical Pathology, St. Vincent's Hospital, University of Melbourne, Victoria, Australia.

出版信息

Zentralbl Pathol. 1994 Aug;140(3):271-5.

PMID:7947635
Abstract

The c-fos gene product is a 55 kd nuclear protein bound to a cellular protein, p39. Expression of the c-fos oncogene is complex in that increased expression occurs in cultured cells during undifferentiated growth but decreased during terminal differentiation. We studied c-fos gene expression by streptavidin-biotin-peroxidase immunohistochemistry in pancreatic adenocarcinoma (N = 20), chronic pancreatitis (N = 9) and normal pancreas (N = 5). One islet cell tumour was included in the study. There was positive staining for c-fos oncoprotein in 15 of the 20 (75%) adenocarcinomas examined (9/12 moderate to poorly differentiated, 6/8 poorly differentiated). The single islet cell tumour investigated was also positive. Only 2 of 9 (22%) cases of chronic pancreatitis and 2 of 5 (40%) normal pancreata were positive. Stromal immunoreactivity was noted in all cancer cases while 5 of 9 (56%) chronic pancreatitis and 3 of 5 (60%) normal pancreas cases showed such staining. In conclusion, c-fos oncoprotein overexpression occurs more frequently in pancreatic cancers compared to chronic pancreatitis and normal pancreas. These findings are consistent with in vitro cell line studies of other cancers which showed increased expression of c-fos during undifferentiated growth.

摘要

c-fos基因产物是一种与细胞蛋白p39结合的55kd核蛋白。c-fos癌基因的表达较为复杂,在培养细胞未分化生长期间表达增加,而在终末分化期间表达降低。我们通过链霉亲和素-生物素-过氧化物酶免疫组化法研究了胰腺癌(N = 20)、慢性胰腺炎(N = 9)和正常胰腺(N = 5)中的c-fos基因表达。研究纳入了1例胰岛细胞瘤。在20例接受检查的腺癌中有15例(75%)c-fos癌蛋白呈阳性染色(12例中9例为中分化至低分化,8例中6例为低分化)。所研究的单个胰岛细胞瘤也呈阳性。9例慢性胰腺炎病例中仅2例(22%)呈阳性,5例正常胰腺病例中2例(40%)呈阳性。在所有癌症病例中均观察到间质免疫反应性,而9例慢性胰腺炎病例中有5例(56%)以及5例正常胰腺病例中有3例(60%)出现这种染色。总之,与慢性胰腺炎和正常胰腺相比,c-fos癌蛋白过表达在胰腺癌中更频繁发生。这些发现与其他癌症的体外细胞系研究一致,后者显示在未分化生长期间c-fos表达增加。

相似文献

1
Immunohistochemical localisation of the c-fos oncoprotein in pancreatic cancers.胰腺癌中c-fos癌蛋白的免疫组织化学定位
Zentralbl Pathol. 1994 Aug;140(3):271-5.
2
Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.人结肠腺瘤和癌中RAS、JUN、FOS及p53癌蛋白表达的免疫组织化学检测
Lab Invest. 1993 Dec;69(6):674-81.
3
Overexpression of heat shock protein (hsp) 70 associated with abnormal p53 expression in cancer of the pancreas.热休克蛋白(hsp)70的过表达与胰腺癌中p53的异常表达相关。
Zentralbl Pathol. 1994 Aug;140(3):259-64.
4
The expression of proto-oncogene c-jun in human pancreatic cancer.原癌基因c-jun在人类胰腺癌中的表达。
Anticancer Res. 1999 Jan-Feb;19(1B):863-7.
5
Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.胰腺腺癌和慢性胰腺炎的分子图谱分析鉴定出了胰腺癌中多个差异表达的基因。
Cancer Res. 2003 May 15;63(10):2649-57.
6
Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.核受体辅激活因子AIB1(SRC-3)在胰腺腺癌进展过程中的过表达。
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6134-42. doi: 10.1158/1078-0432.CCR-04-0561.
7
Down-regulation of BRCA1 in chronic pancreatitis and sporadic pancreatic adenocarcinoma.BRCA1在慢性胰腺炎和散发性胰腺腺癌中的表达下调。
Clin Cancer Res. 2004 Jun 1;10(11):3780-7. doi: 10.1158/1078-0432.CCR-0992-3.
8
The c-erb B-2 proto-oncogene in human pancreatic cancer.人类胰腺癌中的c-erb B-2原癌基因。
J Pathol. 1990 Jul;161(3):195-200. doi: 10.1002/path.1711610305.
9
Immunoelectron study of pancreatic carcinomas using antibodies to gastrointestinal hormones.
Ultrastruct Pathol. 2007 Jul-Aug;31(4):303-14. doi: 10.1080/01913120701456279.
10
Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.胰腺癌发生过程中肌腱蛋白C和膜联蛋白II的表达
J Pathol. 2006 Apr;208(5):673-85. doi: 10.1002/path.1935.

引用本文的文献

1
Pancreatic cancer biomarker detection by two support vector strategies for recursive feature elimination.基于递归特征消除的两种支持向量策略的胰腺癌生物标志物检测。
Biomark Med. 2019 Feb;13(2):105-121. doi: 10.2217/bmm-2018-0273. Epub 2019 Feb 15.
2
The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer.转录因子 Sp1 在胰腺癌中 NFATc2 介导的基因调控中的积极作用。
BMC Biochem. 2019 Jan 29;20(1):2. doi: 10.1186/s12858-019-0105-4.
3
Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer.
c-fos的表达与胰腺癌的临床病理特征及预后相关。
PLoS One. 2015 Mar 19;10(3):e0120332. doi: 10.1371/journal.pone.0120332. eCollection 2015.
4
High-throughput RNAi screening identifies a role for TNK1 in growth and survival of pancreatic cancer cells.高通量 RNAi 筛选鉴定 TNK1 在胰腺癌细胞生长和存活中的作用。
Mol Cancer Res. 2011 Jun;9(6):724-32. doi: 10.1158/1541-7786.MCR-10-0436. Epub 2011 May 2.
5
Towards immunotherapy of pancreatic cancer.迈向胰腺癌的免疫疗法。
Gut. 1999 Jun;44(6):767-9. doi: 10.1136/gut.44.6.767.